Sort
261,768 grants matching “gene therapy”
Derivation of human pluripotent stem cells using small molecules
$1,000,000Yanhong Shi · Beckman Research Institute/City Of Hope · RC1 · FY2010 · NS
Novel Targeted Nanomedicine Delivering MicroRNA-30-5p ReplacementTherapy for Multi-drug Resistant Cancer Treatment
$1,000,000Robert F Place · Mirecule, Inc. · U44 · FY2020 · CA
Long-acting PTH for hypoparathyroidism
$1,000,000Laura M Hales · Extend Biosciences, Inc. · R44 · FY2020 · DK
Production of antibody therapeutic fragments by reduced genome E. coli in continuous culture
$1,000,000Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2020 · AI
Novel extra cellular RNA-based combinatorial RNA inhibition therapy
$1,000,000Anil K Sood · University Of Tx Md Anderson Can Ctr · UH3 · FY2017 · TR
A Human Fc Bifunctional Fusion Protein to Treat Severe Allergic Asthma
$1,000,000Nolan Sigal · Tunitas Therapeutics, Inc. · R44 · FY2014 · AI
Affordable, quantitative, point-of-care microchip-electrophoresis for screening and treatment monitoring of sickle cell disease, thalassemias, and anemias
$1,000,000Peter Galen · Hemex Health, Inc. · R44 · FY2023 · HL
Novel immunotherapy against MOG antibody disease
$1,000,000Weston Daniel · Evoq Therapeutics, Inc. · R44 · FY2024 · TR
A Once-Weekly Oral Tacrolimus-Prednisone Fixed-Dose Combination Therapy for Post-Transplant Maintenance Immunosuppressive Therapy
$1,000,000Stephen Zale · Lyndra Therapeutics, Inc. · R44 · FY2020 · AI
Development of an ALDH2-Targeting RNAi Therapeutic for Alcohol Use Disorders
$1,000,000Henryk Dudek · Dicerna Pharmaceuticals, Inc. · U44 · FY2018 · AA
Creatine Safety and Efficacy in HD: Coordination and Statistical Center
$1,000,000Giovanni Schifitto · University Of Rochester · U01 · FY2014 · AT
A method for accurate and sensitive detection of HIV drug-resistant minority variants
$1,000,000Gary P. Wang · Medosome Biotec, Llc · R42 · FY2023 · AI
Next Generation Autologous TIL Cancer Therapy: Development of GMP manufacturing process
$1,000,000Richard C Duke · Trampoline Pharma, Inc. · R44 · FY2023 · CA
Sequence-based RNA Fluorescence Assay to Measure Latent HIV Reservoirs
$1,000,000Janet L Huie · Jan Biotech, Inc. · R44 · FY2023 · AI
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MI
$1,000,000Saumya Das · Beth Israel Deaconess Medical Center · UH3 · FY2015 · TR
A novel, non-antibiotic, microbiome-directed agent to prevent post-surgical infection
$1,000,000Patrick Hennessey · Covira Surgical · R42 · FY2025 · AI
DEVELOPMENT OF A WNT PATHWAY INHIBITOR FOR METASTATIC COLORECTAL CANCER
$1,000,000Darren Orton · Stemsynergy Therapeutics, Inc. · R44 · FY2017 · CA
Plant-derived HIV neutralizing mAbs for passive immunotherapy in newborn macaques
$1,000,000Yvonne J Rosenberg · Plantvax, Inc. · R44 · FY2017 · AI
Novel Targeted Nanomedicine Delivering MicroRNA-30-5p ReplacementTherapy for Multi-drug Resistant Cancer Treatment
$1,000,000Anthony D Saleh · Mirecule, Inc. · U44 · FY2021 · CA
Improved Sirolimus-Analog Adventitial Delivery to Enhance Outcomes in Below-the-Knee Peripheral Artery Disease
$1,000,000Kirk Seward · Mercator Medsystems, Inc. · R44 · FY2025 · HL
A parallelized computational microscope platform for high-throughput live imaging of patient-derived organoids
$1,000,000Mark Harfouche · Ramona Optics, Inc. · R44 · FY2025 · CA
Human Stem Cell Model of Niemann Pick Type C
$1,000,000Lawrence S Goldstein · University Of California, San Diego · RC1 · FY2010 · NS
Development of WecA-targeting immune potentiators to treat carbapenem-resistant Enterobacteriaceae (CRE) infections
$1,000,000Terry Roemer · Prokaryotics, Inc. · R44 · FY2022 · AI
Clinical Development of a Novel PET Imaging Agent for Prostate Cancer
$1,000,000Alessandro Mascioni · Imaginab, Inc. · R44 · FY2016 · CA
Type III Secretion Inhibitors for Anti-Infective Therapy
$1,000,000Donald T Moir · Microbiotix, Inc · R44 · FY2011 · AI